Inotiv, Inc. (NOTV)

NASDAQ: NOTV · IEX Real-Time Price · USD
3.08
-0.02 (-0.65%)
At close: Sep 29, 2023, 4:00 PM
3.09
+0.01 (0.32%)
After-hours: Sep 29, 2023, 4:10 PM EDT
-0.65%
Market Cap 79.41M
Revenue (ttm) 582.15M
Net Income (ttm) -339.63M
Shares Out 25.78M
EPS (ttm) -13.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 68,363
Open 3.14
Previous Close 3.10
Day's Range 3.08 - 3.18
52-Week Range 2.90 - 23.37
Beta 2.44
Analysts Buy
Price Target 9.00 (+192.21%)
Earnings Date Aug 10, 2023

About NOTV

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial p... [Read more]

Sector Healthcare
IPO Date Nov 24, 1997
Employees 2,099
Stock Exchange NASDAQ
Ticker Symbol NOTV
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for NOTV stock is "Buy." The 12-month stock price forecast is $9.0, which is an increase of 192.21% from the latest price.

Price Target
$9.0
(192.21% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV

NEW YORK , Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Xylem" or the "Company") (NASDAQ: NOTV).

18 hours ago - PRNewsWire

Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.

WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

4 weeks ago - GlobeNewsWire

Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences

WEST LAFAYETTE, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

5 weeks ago - GlobeNewsWire

Inotiv, Inc. (NOTV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK , Aug. 15, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inotiv, Inc. ("Inotiv" or "the Company"...

6 weeks ago - PRNewsWire

Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update

WEST LAFAYETTE, Ind., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

7 weeks ago - GlobeNewsWire

Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023

WEST LAFAYETTE, Ind., July 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

2 months ago - GlobeNewsWire

Inotiv, Inc. to Present at Jefferies 2023 Healthcare Conference

WEST LAFAYETTE, Ind., May 25, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and an...

4 months ago - GlobeNewsWire

Inotiv, Inc. to Participate in May Investor Conferences

WEST LAFAYETTE, Ind., May 19, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and an...

4 months ago - GlobeNewsWire

Inotiv, Inc. Expands Safety Pharmacology Offering to Include Cardiopulmonary Telemetry

WEST LAFAYETTE, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development s...

5 months ago - GlobeNewsWire

Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023

WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and ...

5 months ago - GlobeNewsWire

Inotiv, Inc. Announces First Quarter Fiscal 2023 Financial Results

Reiterates Select Full Year Fiscal 2023 Financial Guidance Reiterates Select Full Year Fiscal 2023 Financial Guidance

8 months ago - GlobeNewsWire

Inotiv, Inc. to Report Fiscal 2023 First Quarter Financial Results and Host Conference Call on Monday, February 13, 2023

WEST LAFAYETTE, Ind., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

8 months ago - GlobeNewsWire

Inotiv Selected as a Winner of the 2023 Top Workplaces USA Award

WEST LAFAYETTE, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

8 months ago - GlobeNewsWire

Inotiv, Inc. Announces Changes to Board of Directors

WEST LAFAYETTE, Ind., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

8 months ago - GlobeNewsWire

Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results

Provides Select First Quarter and Full Year Fiscal 2023 Financial Guidance Provides Select First Quarter and Full Year Fiscal 2023 Financial Guidance

9 months ago - GlobeNewsWire

Inotiv, Inc. to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results and Host Conference Call on Tuesday, January 10, 2023

WEST LAFAYETTE, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

9 months ago - GlobeNewsWire

Inotiv Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - December 28, 2022) - Block & Leviton is investigating Inotiv, Inc. (NASDAQ: NOTV) for potential securities law violations. Investors who have lost money in the...

9 months ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inotiv, Inc. - NOTV

New York, New York--(Newsfile Corp. - December 17, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. ("Inotiv" or the "Company") (NASDAQ: NOTV). Such investors are a...

10 months ago - Newsfile Corp

Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results

Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2022 Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September...

10 months ago - GlobeNewsWire

Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings

WEST LAFAYETTE, Ind., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

10 months ago - GlobeNewsWire

Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process

WEST LAFAYETTE, Ind., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

10 months ago - GlobeNewsWire

Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022

WEST LAFAYETTE, Ind., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

10 months ago - GlobeNewsWire

Inotiv, Inc. to Participate in November Investor Conferences

WEST LAFAYETTE, Ind., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

11 months ago - GlobeNewsWire

Inotiv, Inc. to Participate in September Investor Conferences

WEST LAFAYETTE, Ind., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and a...

1 year ago - GlobeNewsWire

Inotiv Investor Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inotiv To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co...

1 year ago - Newsfile Corp